Your browser doesn't support javascript.
Pattern of Adverse Events Following COVID-19 Vaccine among Vaccinated Individuals Aged Above 18 yrs in Kerala
International Journal of Toxicological and Pharmacological Research ; 13(5):173-179, 2023.
Artículo en Inglés | EMBASE | ID: covidwho-20242942
ABSTRACT

Background:

Coronavirus pandemic is an ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). WHO declared the outbreak as a Public Health Emergency of International Concern in January 2020 & a pandemic in March 2020. In India Oxford University-Astra Zeneca's Covishield vaccine, manufactured by serum institute of India and Bharath Biotech's Covaxin are being used for vaccination programme. In this study, we assess adverse reactions following Covid-19 vaccination & incidence of COVID-19 disease among vaccinated people across Kerala. Since it was newer vaccine and general population was afraid of side effects. The present study aimed to study the adverse effects of COVID-19 vaccination among general population aged above 18 years in Kerala. Method(s) A descriptive cross sectional study was conducted among COVID-19 vaccinated individuals above 18 yrs of age residing in Kerala from July 2021 to December 2021. Pattern of adverse events following COVID-19 vaccination (AEFI) were assessed using a semi structured questionnaire. An online questionnaire using Kobo Toolbox was developed and shared via online platform to record the self-reported adverse events following vaccination. A respondent driven sampling method was used. The data was downloaded in MS Excel and analysed using Microsoft excel. Result(s) Study was conducted among 526 people across Kerala, among which both males(45.63%) and females (54.18%). Majority of them received COVISHEID (92.97%) and rest of them received COVAXIN (6.24%) and SPUTNIK (0.57%). Out of which 65.97% received 2 doses and 34.03% received only one dose of vaccine. More than half of them (61.5%) faced side effects during post vaccination period. The symptoms were very mild in which fever (65.74%) and tiredness (76.85%) were the commonest symptoms. Conclusion(s) In the present study, majority of the vaccinated people experienced very mild and self limiting adverse effects, those were very mild & self limiting. It is a fact that COVID-19 vaccines doesn't provided 100% efficiency, but our study indicates that it does provides protection against COVID-19 infection to a great extend & breakthrough infections are very less severe and asymptomatic for vaccinated people.Copyright © 2023, Dr. Yashwant Research Labs Pvt. Ltd.. All rights reserved.
Palabras clave
Buscar en Google
Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tipo de estudio: Estudio observacional / Investigación cualitativa / Ensayo controlado aleatorizado Tópicos: Vacunas Idioma: Inglés Revista: International Journal of Toxicological and Pharmacological Research Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tipo de estudio: Estudio observacional / Investigación cualitativa / Ensayo controlado aleatorizado Tópicos: Vacunas Idioma: Inglés Revista: International Journal of Toxicological and Pharmacological Research Año: 2023 Tipo del documento: Artículo